Avocet Medical Limited 14555964 false 2025-01-01 2026-02-28 2026-02-28 The principal activity of the company is the provision of medical practice activites. Digita Accounts Production Advanced 6.30.9574.0 true 14555964 2025-01-01 2026-02-28 14555964 2026-02-28 14555964 core:RetainedEarningsAccumulatedLosses 2026-02-28 14555964 core:ShareCapital 2026-02-28 14555964 core:CurrentFinancialInstruments core:WithinOneYear 2026-02-28 14555964 bus:SmallEntities 2025-01-01 2026-02-28 14555964 bus:AuditExemptWithAccountantsReport 2025-01-01 2026-02-28 14555964 bus:FullAccounts 2025-01-01 2026-02-28 14555964 bus:SmallCompaniesRegimeForAccounts 2025-01-01 2026-02-28 14555964 bus:RegisteredOffice 2025-01-01 2026-02-28 14555964 bus:Director2 2025-01-01 2026-02-28 14555964 bus:PrivateLimitedCompanyLtd 2025-01-01 2026-02-28 14555964 1 2025-01-01 2026-02-28 14555964 countries:EnglandWales 2025-01-01 2026-02-28 14555964 2024-01-01 2024-12-31 14555964 2024-12-31 14555964 core:RetainedEarningsAccumulatedLosses 2024-12-31 14555964 core:ShareCapital 2024-12-31 14555964 core:CurrentFinancialInstruments core:WithinOneYear 2024-12-31 iso4217:GBP xbrli:pure

Registration number: 14555964

Avocet Medical Limited

Annual Report and Unaudited Filleted Abridged Financial Statements

for the Period from 1 January 2025 to 28 February 2026

 

Avocet Medical Limited

Contents

Abridged Balance Sheet

1

Notes to the Unaudited Abridged Financial Statements

2

 

Avocet Medical Limited

(Registration number: 14555964)
Abridged Balance Sheet as at 28 February 2026

2026
£

2024
£

Current assets

Debtors

5,171

1

Cash at bank and in hand

1,044

6,210

6,215

6,211

Creditors: Amounts falling due within one year

(6,215)

(7,447)

Net liabilities

-

(1,236)

Capital and reserves

Called up share capital

4

4

Profit and loss account

(4)

(1,240)

Total equity

-

(1,236)

For the financial period ending 28 February 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit of its accounts for the period in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime and the option not to file the Profit and Loss Account has been taken.

All of the company’s members have consented to the preparation of an Abridged Profit and Loss Account and an Abridged Balance Sheet in accordance with Section 444(2A) of the Companies Act 2006.

Approved and authorised by the Board on 15 September 2026 and signed on its behalf by:
 

Mr J Davies

Director

 

Avocet Medical Limited

Notes to the Unaudited Abridged Financial Statements for the Period from 1 January 2025 to 28 February 2026

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
Calyx House
South Road
Taunton
Somerset
TA1 3DU

These financial statements were authorised for issue by the Board on 15 September 2026.

2

Accounting policies

Statement of compliance

These abridged financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These abridged financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Disclosure of long or short period

These accounts have been prepared for a period longer than one year as this is the final period of trading prior to selling the company.

3

Staff numbers

The average number of persons employed by the company (including directors) during the period, was 4 (2024 - 4).